Pharmacological activation of ACE2 in symptomatic Tg2576 mice was found to reduce Aβ42 and IL1-β levels in the hippocampus and protect from cognitive decline, suggesting that ACE2 expression may exert a positive function in Aβ-related cognitive disorders [71]. The gene discussed is ACE2; the disease is Cognitive impairment.